These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3501542)

  • 1. Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid.
    Machover D; Goldschmidt E; Chollet P; Metzger G; Zittoun J; Benavides M; Marquet J; Vandenbulcke JM; Misset JL; Schwarzenberg L
    NCI Monogr; 1987; (5):193-8. PubMed ID: 3501542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid.
    Machover D; Goldschmidt E; Chollet P; Metzger G; Zittoun J; Marquet J; Vandenbulcke JM; Misset JL; Schwarzenberg L; Fourtillan JB
    J Clin Oncol; 1986 May; 4(5):685-96. PubMed ID: 3517242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil combined with high-dose folinic acid. An update.
    Machover D; Goldschmidt E; Schwarzenberg L; Vanden-Bulcke JM; Misset JL; Chollet P; Mathé G
    Chemioterapia; 1985 Oct; 4(5):369-76. PubMed ID: 3878231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologic modulation of 5-fluorouracil with high-dose leucovorin and combination chemotherapy of 5-fluorouracil and cisplatin in metastatic colorectal adenocarcinoma.
    Petrelli NJ; Madajewicz S; Herrera L; Rustum YM; Trave F; Creaven P; Mittelman A
    NCI Monogr; 1987; (5):189-92. PubMed ID: 3501541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatin, etoposide, and weekly high-dose 5-fluorouracil and leucovorin infusion (PE-HDFL)--a very effective regimen with good patients' compliance for advanced gastric cancer.
    Cheng AL; Yeh KH; Lin JT; Hsu C; Liu MY
    Anticancer Res; 1998; 18(2B):1267-72. PubMed ID: 9615799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase II trial of 5-fluorouracil and high-dose leucovorin in gastric carcinoma and a phase I trial of intraperitoneal 5-fluorouracil and leucovorin.
    Arbuck SG; Douglass HO; Trave F; Rustum YM
    NCI Monogr; 1987; (5):203-5. PubMed ID: 3501544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical studies of biochemical modulation of 5-fluorouracil by leucovorin in patients with advanced colorectal cancer by the North Central Cancer Treatment Group and Mayo Clinic.
    O'Connell MJ; Klaassen DJ; Everson LK; Cullinan S; Wieand HS
    NCI Monogr; 1987; (5):185-8. PubMed ID: 3501540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paclitaxel and weekly 24-hour infusion of 5-fluorouracil/folinic acid in advanced gastric cancer.
    Bokemeyer C; Hartmann JT; Lampe CS; Clemens MR; Quietzsch D; Forkmann L; Kanz L
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-96-S19-100. PubMed ID: 9427277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chronotherapy with high dose carboplatin, 5-fluorouracil and leucovorin in advanced colorectal carcinoma].
    Popov I; Jelić S; Radosavljević D; Nikolić-Tomasević A
    Srp Arh Celok Lek; 1998; 126(9-10):355-61. PubMed ID: 9863407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Schedule-selective biochemical modulation of 5-fluorouracil: a phase II study in advanced colorectal cancer.
    Sobrero AF; Aschele C; Guglielmi AP; Mori AM; Tixi LM; Bolli EA; Rosso R; Mammoliti S; Rollandi GA; Bertoglio S
    Clin Cancer Res; 1995 Sep; 1(9):955-60. PubMed ID: 9816066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
    Gebbia V; Majello E; Testa A; Pezzella G; Giuseppe S; Giotta F; Riccardi F; Fortunato S; Colucci G; Gebbia N
    Cancer; 1996 Sep; 78(6):1300-7. PubMed ID: 8826954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Northern California Oncology Group randomized trial of leucovorin plus 5-fluorouracil versus sequential methotrexate, 5-fluorouracil, and leucovorin in patients with advanced colorectal cancer who failed treatment with 5-fluorouracil or 5-fluorodeoxyuridine alone.
    Valone FH; Kohler M; Fisher K; Hannigan J; Flam M; Gandara D; Hendrickson C; Richman E; Yu KP
    NCI Monogr; 1987; (5):175-7. PubMed ID: 2963230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
    Klaassen U; Wilke H; Seeber S
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of rectocolic and gastric adenocarcinomas with 5-fluorouracil associated with high doses of folinic acid. Results of an experimental study].
    Machover D; Schwarzenberg L; Goldschmidt E; Tourani JM; Michalski B; Hayat M; Dorval T; Misset JL; Delouche C; Brochon D; Fraioli JP; Jasmin C; Maral R; Mathe G
    Sem Hop; 1982 Sep; 58(33):1873-5. PubMed ID: 6293063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [5-fluorouracil, high dose folinic acid and mitomycin C in the treatment of advanced digestive cancers].
    Seitz JF; Diaw A; Giovannini M; Perrier H; Gouvernet J
    Bull Cancer; 1994 Feb; 81(2):134-7. PubMed ID: 7894119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase II study of 5-fluorouracil, leucovorin, and interferon-alpha in the treatment of patients with metastatic or recurrent gastric carcinoma: an Eastern Cooperative Oncology Group study (E5292).
    Hudes GR; Lipsitz S; Grem J; Morrisey M; Weiner L; Kugler JW; Benson A
    Cancer; 1999 Jan; 85(2):290-4. PubMed ID: 10023694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase II study of weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin (HDFL) in the treatment of recurrent or metastatic colorectal cancers.
    Yeh KH; Cheng AL; Lin MT; Hong RL; Hsu CH; Lin JF; Chang KJ; Lee PH; Chen YC
    Anticancer Res; 1997; 17(5B):3867-71. PubMed ID: 9427794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized multicenter phase II trial of bolus plus infusional fluorouracil/leucovorin compared with fluorouracil/leucovorin plus oxaliplatin as third-line treatment of patients with advanced colorectal cancer.
    Kemeny N; Garay CA; Gurtler J; Hochster H; Kennedy P; Benson A; Brandt DS; Polikoff J; Wertheim M; Shumaker G; Hallman D; Burger B; Gupta S
    J Clin Oncol; 2004 Dec; 22(23):4753-61. PubMed ID: 15570076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II trial of biweekly infusional fluorouracil, folinic acid, and oxaliplatin in patients with advanced gastric cancer.
    Al-Batran SE; Atmaca A; Hegewisch-Becker S; Jaeger D; Hahnfeld S; Rummel MJ; Seipelt G; Rost A; Orth J; Knuth A; Jaeger E
    J Clin Oncol; 2004 Feb; 22(4):658-63. PubMed ID: 14966088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weekly high-dose 5-fluorouracil as a 24-h infusion and sodium folinic acid (AIO regimen) plus irinotecan in patients with locally advanced nonresectable and metastatic adenocarcinoma or squamous cell carcinoma of the oesophagus: a phase II trial.
    Wolff K; Wein A; Reulbach U; Männlein G; Brückl V; Meier C; Ostermeier N; Schwab SA; Horbach T; Hohenberger W; Hahn EG; Boxberger F
    Anticancer Drugs; 2009 Mar; 20(3):165-73. PubMed ID: 19125117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.